Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RDN | ENVA |
|---|---|---|
| Price | $33.50 | $178.00 |
| Change today | ▲ 2.86% | ▲ 2.96% |
| Market cap | $4.43B | $4.43B |
| Return, 3 months | -11.3% | -24.9% |
| Return, year to date | -4.8% | +13.2% |
| Return, 1 year | -0.7% | +61.1% |
| P/E (TTM) | 8.6 | 13.2 |
| P/B | 0.9 | 3.0 |
| P/E percentile vs own 5y | – | 75th |
| Dividend yield | 3.04% | – |
| Revenue growth (YoY, latest qtr) | +92.6% | +18.6% |
| Net profit growth (YoY) | -18.3% | +47.2% |
| Gross margin | – | 47.3% |
| Operating margin | – | 12.9% |
| Net margin | 20.2% | 9.8% |
| Return on equity | – | – |
| Analyst target vs. price | +30.1% | +50.9% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 45 | 38 |
| 30-day volatility | 30.9% | 82.8% |
| Max drawdown, 1 year | -22.4% | -37.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
